Short-term treatment with estrogen as a preventive strategy against postpartum depression (MAMA)
The Maternal Mental Health (MAMA) trial is a placebo-controlled trial evaluating the preventive effect of transdermal estradiol treatment in the immediate postpartum on depressive episodes. The trial is conducted in a multi-center setting involving maternity wards at three university hospitals in the Capital Region of Denmark.
Read more details about the trial in either Danish or English via the links below.
220 women and their 220 infants are expected to participate in the MAMA trial.
The enrollment status is displayed to the left.
Project-related tweets from @mama_trial: